Table 3.
Logistic Regression Analysis of Associated Factors of AF Patients with Beta-Blockers
| Univariable Analysis | Multivariable Analysis | |||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| Female | 1.01 (0.58–1.76) | 0.973 | 1.13 (0.34–3.79) | 0.840 |
| Age | 0.99 (0.96–1.02) | 0.556 | 0.97 (0.91–1.04) | 0.457 |
| BMI | 1.06 (0.99–1.14) | 0.109 | 1.06 (0.97–1.15) | 0.209 |
| SBP | 0.99 (0.98–1.00) | 0.087 | 0.98 (0.97–1.00) | 0.091 |
| DBP | 0.99 (0.97–1.00) | 0.107 | 1.00 (0.97–1.02) | 0.803 |
| Heart rate | 1.00 (0.99–1.01) | 0.950 | 1.01 (0.99–1.02) | 0.411 |
| AF_type | ||||
| Paroxysmal | 2.98 (1.24–7.67) | 0.018 | 2.04 (0.73–5.93) | 0.180 |
| Permanent | 1.98 (0.91–4.69) | 0.099 | 1.95 (0.79–5.19) | 0.161 |
| Myocardial Infarction | 4.20 (1.68–11.09) | 0.002 | 4.20 (0.94–20.05) | 0.064 |
| Coronary artery disease | 1.85 (1.05–3.32) | 0.035 | 1.29 (0.62–2.68) | 0.494 |
| Heart failure | 0.57 (0.32–1.00) | 0.051 | 0.48 (0.15–1.56) | 0.228 |
| Hypertension | 2.43 (1.35–4.50) | 0.004 | 3.35 (0.93–12.52) | 0.067 |
| LVH | 0.62 (0.27–1.34) | 0.248 | 0.39 (0.12–1.13) | 0.093 |
| Previous stroke or TIA | 2.26 (1.20–4.26) | 0.011 | 2.10 (0.29–15.62) | 0.465 |
| Sleep apnea | 0.31 (0.02–1.78) | 0.277 | 0.22 (0.01–1.58) | 0.198 |
| Tobacco use | 0.77 (0.42–1.39) | 0.398 | 1.41 (0.64–3.15) | 0.396 |
| LVSD | 1.03 (0.52–1.98) | 0.939 | 1.90 (0.69–5.38) | 0.217 |
| Dementia | 0.63 (0.09–2.67) | 0.568 | 0.27 (0.03–1.75) | 0.209 |
| Diabetes mellitus | 1.37 (0.65–2.81) | 0.391 | 0.73 (0.20–2.60) | 0.624 |
| Hyperthyroidism | 1.50 (0.19–9.25) | 0.660 | 1.00 (0.09–8.56) | 0.999 |
| Prior major bleeding | 1.70 (0.33–7.92) | 0.493 | 2.80 (0.33–24.90) | 0.339 |
| CHA2DS2-VaSc score | 1.20 (1.02–1.42) | 0.030 | 0.87 (0.35–2.18) | 0.768 |
Abbreviations: AF, atrial fibrillation; BMI, body mass index; DBP, diastolic blood pressure; LVH, levy left ventricular hypertrophy; LVSD, left ventricular systolic dysfunction; SBP, systolic blood pressure; TIA, transient ischemic attack.